SecProbe.io - Filing

CORRESP Filing

Bone Biologics Corp
Date: Aug. 29, 2025 · CIK: 0001419554 · Accession: 0001493152-25-012469

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-288290

Date

Aug. 29, 2025

Author

President

Form

CORRESP

Company

Bone Biologics Corp

Letter

Bone Biologics Corporation

Burlington Woods Drive, Suite 100

Burlington, MA 01803

August 29, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attn: Jane Park

Re: Bone Biologics Corporation Registration Statement on Form S-3 File No. 333-288290

Ladies and Gentlemen:

In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Bone Biologics Corporation, a Delaware corporation, hereby requests that the effectiveness of the registration statement on Form S-3 (File No. 333-288290 ), initially filed with the U.S. Securities and Exchange Commission on June 24, 2025, as amended by Pre-Effective Amendment No. 1 filed on August 29, 2025, be accelerated so that the registration statement becomes effective at 4:30 p.m. Eastern Time on September 2, 2025 or as soon thereafter as practicable.

If you have any questions regarding this request, please contact Alexander R. McClean of Harter Secrest & Emery at (585) 231-1248.

Very
truly yours,
Bone
Biologics Corporation

Show Raw Text

CORRESP
 1
 filename1.htm

 Bone
Biologics Corporation

 2
Burlington Woods Drive, Suite 100

 Burlington,
MA 01803

 August
29, 2025

 VIA
EDGAR

 U.S.
Securities and Exchange Commission

 Division
of Corporation Finance

 100
F Street, N.E.

 Washington,
D.C. 20549

 Attn:
Jane Park

 Re:
 Bone
 Biologics Corporation
 Registration
 Statement on Form S-3
 File
 No. 333-288290

 Ladies
and Gentlemen:

 In
accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Bone Biologics Corporation, a Delaware corporation,
hereby requests that the effectiveness of the registration statement on Form S-3 (File No. 333-288290 ), initially filed with the
U.S. Securities and Exchange Commission on June 24, 2025, as amended by Pre-Effective Amendment No. 1 filed on August 29, 2025, be accelerated
so that the registration statement becomes effective at 4:30 p.m. Eastern Time on September 2, 2025 or as soon thereafter as practicable.

 If
you have any questions regarding this request, please contact Alexander R. McClean of Harter Secrest & Emery at (585) 231-1248.

 Very
 truly yours,

 Bone
 Biologics Corporation

 By:
 /s/
 Jeffrey Frelick

 Jeffrey
 Frelick

 President
 and Chief Executive Officer